Analyzing the genomes of twin sisters -- one healthy and one with aggressive leukemia -- led an international team of researchers to identify a novel molecular target that could become a way to treat recurring and deadly malignancies. Scientists report their findings online Feb. 9 in Nature Genetics. The study points to a molecular pathway involving a gene called SETD2, which can mutate in blood cells during a critical step as DNA is being transcribed and replicated.
Fuente : http://www.eurekalert.org/pub_releases/2014-02/cch...
Fuente : http://www.eurekalert.org/pub_releases/2014-02/cch...